CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
Oncology Today with Dr Neil Love
00:00
Long-term risks and second cancers
Paul discusses lower preclinical second-cancer risk versus lenalidomide and implications for maintenance use.
Play episode from 20:12
Transcript
